Perbedaan Sinergi Inti Andalan Prima Tbk. dan Merck Tbk.: Sinergi Inti Andalan Prima Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 4,79 T, volume 24 jam 416,84 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Sinergi Inti Andalan Prima Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Merck Tbk., dan Sinergi Inti Andalan Prima Tbk. lebih aktif diperdagangkan (416,84 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| INET | MERK | |
|---|---|---|
Kapitalisasi Pasar | 4,79 T | 1,7 T |
Volume | 416,84 jt | 37,6 rb |
Lot | 4,17 jt | 376 |
Perputaran | 93,24 M | 144,47 jt |
Harga Rata-rata | 223,69 | 3.842,23 |
Nilai Transaksi | 93,24 M | 144,47 jt |
Harga Ekuilibrium Indikatif | 224 | 3.840 |
Volume Ekuilibrium Indikatif | 89,2 rb | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.
Selengkapnya di halaman INET →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →